Loading...

UCB SA

UCBJY•PNK
Healthcare
Biotechnology
$101.66
$0.51(0.50%)

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap39.3B
P/E Ratio141.07
EPS (TTM)$3.22
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Week$92.51
1 Month$100.00
3 Months$71.17
1 Year Target$150.58

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $150.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 141.07 and a market capitalization of 39.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;